The program covers updates on collaborative initiatives and implementation of precision cancer medicine across the Nordics as well as in other European countries and beyond.
Program details will be available soon. Already confirmed speakers are listed under "Speakers".
September 17-19, 2023
Oslo, Norway
September 17
Get together
September 18
Keynote Speaker David Thomas, Garvan Institute of Medical Research, Australia
Omico: Australia's Genomic Cancer Medicine Centre (40 + 5 min)
Funda Meric-Bernstam, MD Anderson Cancer Centre, USA
Tyler Seibert, University of California San Diego, USA:
Maud Kamal, Institut Curie, Paris
Pitt Niehusmann, Oslo University Hospital, Norway:
Lynette Sholl, Dana-Farber / Harvard Cancer Center, USA
Lunch
Poster Session
Keynote Speaker Francesco Pignatti, European Medicines Agency (EMA): Pan-cancer/Histology-agnostic drug development (25 + 5 min)
Christophe Le Tourneau, Institut Curie, Paris
Anita Sveen, Oslo University Hospital, Norway
Emile Voest, NCI, The Netherlands
Guro Giskeødegård, NTNU, Norway:
Richard Schilsky, University of Chicago, USA
Aperitif in the reception area
Dinner
September 19
Keynote Speaker Gordon Mills, Knight Cancer Institute, OHSU, USA:
Targeting adaptive responses in cancer through SMMART clinical trials (40 + 5 min)
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, CZ Health Insurance, The Netherlands
Katarina Steen Carlsson, The Swedish Institute for Health Economics, Sweden
Bettina Ryll, Stockholm School of Economics, Sweden
Bjørn Hofmann, University of Oslo, Norway
Monika Frenzel, French National Research Agency
Lunch
Jesus Garcia-Foncillas, Jiménez Diaz Foundation University Hospital, Madrid, Spain
Sigve Nakken, Oslo University Hospital, Norway:
Benedikt Westphalen, LMU Munich, Germany
Kadri Toome, Tartu University Hospital, Estonia:
Coffee Break
Hans Gelderblom, Leiden University Medical Centre, The Netherlands
Åslaug Helland, Oslo University Hospital, Oslo, Norway
Kristoffer Staal Rohrberg, Rigshospitalet, Copenhagen, Denmark
Katriina Jalkanen, Helsinki University Hospital, Finland
Loic Verlingue, Centre Léon Bérard, Lyon, France
Matthew Krebs, University of Manchester, UK
Maeve Lowery, Trinity College Dublin and St James Hospital, Ireland
Kjetil Taskén, Oslo University Hospital, Norway
Panel debate / Q&A (speakers +Edvard Abel and Julio Oliveira)
Concluding Remarks
An Acta Oncologica Conference
The overarching theme of this two-day conference is precision cancer medicine. Internationally renowned speakers will give scientific updates as well as updates on collaborative initiatives and implementation of precision cancer medicine across the Nordics and other European countries. Furthermore, patient benefit and visions for the future, including standard health care, is on the agenda.